Blog
RSS FeedPosted by Michael Wonder on 30 Jun 2020
Companies have raised prices on 245 drugs during pandemic, advocacy group says
29 June 2020 - Pharmaceutical companies have raised prices on 245 drugs since the first U.S. coronavirus case was reported ...
Posted by Michael Wonder on 30 Jun 2020
Canada federal court dismisses drug makers' plea challenging drug price rules
30 June 2020 - The federal court of Canada on Monday dismissed a plea by drug makers challenging the Canadian ...
Posted by Michael Wonder on 29 Jun 2020
IMC responds to Federal Court decision regarding PMPRB regulatory changes
29 June 2020 - Innovative Medicines Canada released the following statement today in response to the Federal Court of Canada’s ...
Posted by Michael Wonder on 29 Jun 2020
‘Government should lower prices of generic drugs’
29 June 2020 - “Our policy should aim at reaching the OECD average of general drug use, additionally cut generic ...
Posted by Michael Wonder on 29 Jun 2020
Gilead sets price for coronavirus drug remdesivir at $2,340, sparking criticism
30 June 2020 - The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says ...
Posted by Michael Wonder on 28 Jun 2020
As the coronavirus spreads, drug pricing legislation remains stalled
27 June 2020 - For both parties, taking action to reduce the cost of prescription drugs was a banner policy issue ...
Posted by Michael Wonder on 25 Jun 2020
Federal prosecutors allege Regeneron used a charity to pay kickbacks to Medicare patients
24 June 2020 - Federal officials on Wednesday alleged that Regeneron Pharmaceuticals donated tens of millions of dollars to a ...
Posted by Michael Wonder on 25 Jun 2020
Price disclosure October 2020 cycle outcomes summary
25 June 2020 - The summary of price disclosure price reductions for the October 2020 Cycle has now been published. ...
Posted by Michael Wonder on 24 Jun 2020
ICER provides first update to pricing models for remdesivir as a treatment for COVID-19
24 June 2020 - Updated cost-recovery benchmark price now framed as a range with maximum of $1,600/10 day regimen when incorporating ...
Posted by Michael Wonder on 23 Jun 2020
Pricing remdesivir: a domestic reference price approach
23 June 2020 - As COVID-19 continues to ravage US communities, the costs in terms of lives and lost wages are ...
Posted by Michael Wonder on 22 Jun 2020
PMPRB publishes new draft guidelines, launches 30 day consultation
22 June 2020 - As reported earlier this month, the Patented Medicine Prices Review Board has published a new draft ...
Posted by Michael Wonder on 22 Jun 2020
‘Pfizer’s Vyndaqel, Vyndamax do not deserve rare disease pricing’
22 June 2020 - Pfizer’s Vyndaqel and Vyndamax -- containing tafamidis to treat cardiomyopathy caused by transthyretin amyloidosis (ATTR-CM) -- do ...
Posted by Michael Wonder on 20 Jun 2020
ICER to assess whether the most significant prescription drug price increases are supported by new clinical evidence
19 June 2020 - Public input on drugs of concern will be accepted through 17 July 2020. ...
Posted by Michael Wonder on 18 Jun 2020
Trump administration seeks to encourage ‘value-based’ drug pricing deals with new proposal
17 June 2020 - The Trump administration wants to revamp certain Medicaid rules about drug prices in hopes of encouraging ...
Posted by Michael Wonder on 18 Jun 2020
US court nixes drug maker price disclosure
18 June 2020 - A US court has ruled against a move by President Donald Trump's administration to try to bring ...